New $1.2 Billion Firm Aims to Clone Supercharged Dogs for the U.S. Military

Warhound, a stealth startup emerging from the orbit of two high-profile tech figures, has secured $200 million in new capital to genetically engineer and equip working dogs for the U.S. military and emergency response teams. The fresh round, which values the company at $1.2 billion, brings a coalition of investors including Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a venture firm with backing from the CIA and other U.S. intelligence agencies.

The financial backing is significant, but the strategic rationale is rooted in a supply chain vulnerability. According to the company’s launch announcement, more than 80% of the U.S. military’s working dogs are currently sourced from Europe. Furthermore, the data indicates that fewer than half of these imported animals are fit for service upon arrival. This reliance on foreign breeding has created a dwindling domestic supply of canines that play critical roles in bomb detection, searches, and other specialized operations.

Warhound was founded on a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey, the co-founder of Anduril. Lamm noted that he met Luckey approximately a year ago at a conference where the Anduril executive expressed concern over the state of military working dogs. This conversation led Lamm to research breeding practices, revealing that many dogs fail training due to inherited issues such as poor eyesight, high cancer risks, hip dysplasia, or muscle atrophy.

To address these biological limitations, Lamm’s team has begun studying top-performing breeds, specifically the Belgian Malinois and the German Shepherd. The company is maintaining a biobank of living cell lines from these animals. The plan is to use gene editing to remove detrimental traits and add genetic markers that improve performance, health, and longevity. Lamm described the goal as creating a new type of dog with enhanced speed, agility, and olfactory sensors specifically suited for demanding missions.

The business model combines biological engineering with hardware and software integration. Anduril will provide the technological layer, supplying protection vests, goggles, and other gear designed to assist both the dogs and their handlers. Lamm explained that this equipment will feature data sensors, such as those in bulletproof vests, that transmit real-time information to handlers to improve situational awareness. He emphasized that these technological additions are meant to operate "on top of the dog, not in the dog," ensuring the animals are safer and healthier beyond just their genetics.

The corporate structure involves distinct roles for the partners. Lamm clarified that while Luckey is a venture partner, he holds no equity in Warhound. Instead, Colossal Biosciences owns equity in the business and supports the venture by licensing its proprietary technology. Colossal, known for its de-extinction efforts to revive species like the mammoth, is leveraging its existing work in AI-driven gene cloning and identification.

Production is already underway, with the first batch of dogs slated for cloning and incubation in the near future. Births are expected early next year, with the aim of having the first units in service within two years. Viagen, another company under the Colossal umbrella, will partner with Warhound to handle the cloning process. Lamm noted that Viagen’s technology boasts a high success rate, a capability Colossal already utilizes in its programs to protect endangered species.

While the company has not yet determined its pricing structure, it expects to sell to first responders, the Department of Defense, military service groups, and police forces. Regarding regulatory hurdles, Lamm stated that the company has briefed numerous government groups. On the matter of civilian safety, he assured that each dog will be trained like any other military working dog and managed by its purchasing agency.

The venture is also working under the guidance of the American Humane Society to certify its training programs. The partnership aims to ensure that when these new dogs retire, they can enter the Society’s Military Working Dog Reunification Program or other assistance programs. The American Humane Society issued a statement applauding Warhound and Colossal for inviting the organization to the table, saying it looks forward to ensuring the animals are treated humanely.